Mindfulness program aims to help cancer survivors kick smoking and cut alcohol
NCT ID NCT07447635
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 9-week mindfulness program (MBRP-SA) designed to help cancer survivors quit smoking and reduce heavy drinking. Six hundred participants in Florida will either get the mindfulness program plus nicotine patches or standard quitline support. The goal is to see if mindfulness can reduce cravings and stress better than usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) plus nicotine replacement therapy
- What this could lead to
- If it works, this could offer a practical, non-drug way to help cancer survivors quit smoking and cut down on heavy drinking, improving their long-term health.
- What could go wrong
- This is a behavioral study, not a drug trial, so results may vary widely. The program is intensive (9 weeks of group sessions), and success depends on individual commitment. It's also limited to Florida residents.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?